CY2023 Q4
Showing 1 to 14 of 14 rows
Loading, please wait
Company
|
Value
|
End Date
|
SEC Filing
|
|---|---|---|---|
| AMERIPRISE FINANCIAL, INC. | $1,945,000,000.00 | 2023-12-31 | View |
| ARCUTIS BIOTHERAPEUTICS, INC. | $849,000.00 | 2023-12-31 | View |
| AYRO, INC. | $9,400,000.00 | 2023-12-31 | View |
| BROOKFIELD REINSURANCE LTD. | $872,000,000.00 | 2023-12-31 | View |
| CNO Financial Group, Inc. | $83,000,000.00 | 2023-12-31 | View |
| EQUINIX, INC. | $223,000,000.00 | 2023-12-31 | View |
| IMMUNITYBIO, INC. | $800,000.00 | 2023-12-31 | View |
| MARA HOLDINGS, INC. | $0.00 | 2023-12-31 | View |
| NATIONAL WESTERN LIFE GROUP, INC. | $-280,400,000.00 | 2023-12-31 | View |
| PHARMACYTE BIOTECH, INC. | $3,400,000.00 | 2024-01-31 | View |
| PRUCO LIFE INSURANCE CO | $-7,505,000,000.00 | 2023-12-31 | View |
| PRUCO LIFE INSURANCE OF NEW JERSEY | $-168,000,000.00 | 2023-12-31 | View |
| PRUDENTIAL FINANCIAL INC | $-8,096,000,000.00 | 2023-12-31 | View |
| The Goldman Sachs Group, Inc. | $143,000,000.00 | 2023-12-31 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations